# MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial

> **NCT05621590** · EARLY_PHASE1 · COMPLETED · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 35 (actual)

## Conditions studied

- Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest

## Interventions

- **DRUG:** MLC 901
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05621590
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-10
- **Primary completion:** 2022-08-12
- **Final completion:** 2022-08-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2022-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05621590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05621590, "MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05621590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*